相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PATHOGENESIS OF DEPRESSION: INSIGHTS FROM HUMAN AND RODENT STUDIES
C. Menard et al.
NEUROSCIENCE (2016)
Ketamine as a promising prototype for a new generation of rapid-acting antidepressants
Chadi G. Abdallah et al.
TRANSLATIONAL NEUROSCIENCE IN PSYCHIATRY (2015)
The importance of cytokines and autoantibodies in depression
Mariana Postal et al.
AUTOIMMUNITY REVIEWS (2015)
Targeting Brain Nicotinic Acetylcholine Receptors to Treat Major Depression and Co-Morbid Alcohol or Nicotine Addiction
Shafiqur Rahman
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2015)
How does ketamine elicit a rapid antidepressant response?
Ege T. Kavalali et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Nicotine-Derived Compounds as Therapeutic Tools Against Post-Traumatic Stress Disorder
George E. Barreto et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Curcumin as a putative antidepressant
Ho-Jun Seo et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
BDNF Val66Met polymorphism in patterns of neural activation in individuals with MDD and healthy controls
Danuta M. Lisiecka et al.
JOURNAL OF AFFECTIVE DISORDERS (2015)
The Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Paul E. Greenberg et al.
JOURNAL OF CLINICAL PSYCHIATRY (2015)
An Act of Balance Between Adaptive and Maladaptive Immunity in Depression: a Role for T Lymphocytes
Catherine Toben et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
Curcumin improves neural function after spinal cord injury by the joint inhibition of the intracellular and extracellular components of glial scar
Jichao Yuan et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Resveratrol neuroprotection in stroke and traumatic CNS injury
Mary S. Lopez et al.
NEUROCHEMISTRY INTERNATIONAL (2015)
Polymerized nano-curcumin attenuates neurological symptoms in EAE model of multiple sclerosis through down regulation of inflammatory and oxidative processes and enhancing neuroprotection and myelin repair
Maryam Mohajeri et al.
NEUROPHARMACOLOGY (2015)
Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states
Marina R. Picciotto et al.
NEUROPHARMACOLOGY (2015)
Translating depression biomarkers for improved targeted therapies
David S. Bredt et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
The role of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in depression: Central mediators of pathophysiology and antidepressant activity?
Florian Freudenberg et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Fluoxetine enhanced neurogenesis is not translated to functional outcome in stroke rats
Xiaoyu Sun et al.
NEUROSCIENCE LETTERS (2015)
BDNF/TRKB/P75NTR polymorphisms and their consequences on antidepressant efficacy in depressed patients
Romain Colle et al.
PHARMACOGENOMICS (2015)
Integrating the monoamine, neurotrophin and cytokine hypotheses of depression - A central role for the serotonin transporter?
Jana Haase et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Resveratrol ameliorates depressive-like behavior in repeated corticosterone-induced depression in mice
Syed Hamid Ali et al.
STEROIDS (2015)
Fluoxetine Maintains a State of Heightened Responsiveness to Motor Training Early After Stroke in a Mouse Model
Kwan L. Ng et al.
STROKE (2015)
Role of the 5-HT4 receptor in chronic fluoxetine treatment-induced neurogenic activity and granule cell dematuration in the dentate gyrus
Yuki Imoto et al.
MOLECULAR BRAIN (2015)
Curcumin as a putative antidepressant
Ho-Jun Seo et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Gene–Environment Interaction in Major Depression: Focus on Experience-Dependent Biological Systems
Nicola Lopizzo et al.
Frontiers in Psychiatry (2015)
Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review
Nicolas D. Iadarola et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2015)
Investigation of the Efficacy of Adjunctive Therapy with Bioavailability-Boosted Curcuminoids in Major Depressive Disorder
Yunes Panahi et al.
PHYTOTHERAPY RESEARCH (2015)
An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline
Rudolf Uher et al.
AMERICAN JOURNAL OF PSYCHIATRY (2014)
Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols
Subash C. Gupta et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2014)
Effects of curcumin on learning and memory deficits, BDNF, and ERK protein expression in rats exposed to chronic unpredictable stress
Dexiang Liu et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
The effects of curcumin on depressive-like behavior in mice after lipopolysaccharide administration
Zhen Wang et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Antidepressant effects of resveratrol in an animal model of depression
Laura L. Hurley et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
NMDA-receptor antagonists block B-cell function but foster IL-10 production in BCR/CD40-activated B cells
Narasimhulu Simma et al.
CELL COMMUNICATION AND SIGNALING (2014)
Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications
George Anderson et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
Protective Effects of Anesthetics on the Spinal Cord
Manabu Kakinohana
CURRENT PHARMACEUTICAL DESIGN (2014)
Curcumin protects axons from degeneration in the setting of local neuroinflammation
Million Adane Tegenge et al.
EXPERIMENTAL NEUROLOGY (2014)
Curcumin inhibits microglia inflammation and confers neuroprotection in intracerebral hemorrhage
Zhao Yang et al.
IMMUNOLOGY LETTERS (2014)
Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: Possible role of SOCS-1 in reducing pro-inflammatory responses
Dario D. Lofrumento et al.
INNATE IMMUNITY (2014)
Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
C. N. Haile et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Effects of curcumin on chronic, unpredictable, mild, stress-induced depressive-like behaviour and structural plasticity in the lateral amygdala of rats
Lin Zhang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Curcumin for the treatment of major depression: A randomised, double-blind, placebo controlled study
Adrian L. Lopresti et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Molecular and genetic basis of depression
Madhumita Roy et al.
JOURNAL OF GENETICS (2014)
Effects of Curcumin (Curcuma longa) on Learning and Spatial Memory as Well as Cell Proliferation and Neuroblast Differentiation in Adult and Aged Mice by Upregulating Brain-Derived Neurotrophic Factor and CREB Signaling
Sung Min Nam et al.
JOURNAL OF MEDICINAL FOOD (2014)
Relevance of the Anti-Inflammatory Properties of Curcumin in Neurodegenerative Diseases and Depression
Yousef Tizabi et al.
MOLECULES (2014)
Immunology of Major Depression
Norbert Mueller
NEUROIMMUNOMODULATION (2014)
Protective Effects of Curcumin Against Rotenone and Salsolinol-Induced Toxicity: Implications for Parkinson's Disease
Zakiya Qualls et al.
NEUROTOXICITY RESEARCH (2014)
Neuroprotective effect of curcumin on hippocampal injury in 6-OHDA-induced Parkinson's disease rat
Jiaqing Yang et al.
PATHOLOGY RESEARCH AND PRACTICE (2014)
The role of the neuroendocrine and immune systems in the pathogenesis of depression
Ewa Oglodek et al.
PHARMACOLOGICAL REPORTS (2014)
Role for the nicotinic cholinergic system in movement disorders; therapeutic implications
Maryka Quik et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Resveratrol prevents impaired cognition induced by chronic unpredictable mild stress in rats
Dexiang Liu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
An Antidepressant Decreases CSF Aβ Production in Healthy Individuals and in Transgenic AD Mice
Yvette I. Sheline et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Curcumin as a Therapeutic Agent in Dementia: A Mini Systematic Review of Human Studies
Natascia Brondino et al.
SCIENTIFIC WORLD JOURNAL (2014)
Rodent Models of Depression: Neurotrophic and Neuroinflammatory Biomarkers
Mikhail Stepanichev et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Therapeutic Modalities for Treatment Resistant Depression: Focus on Vagal Nerve Stimulation and Ketamine
Aparna Shah et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2014)
Antidepressants for neuro-regeneration: from depression to Alzheimer's disease
Hyun-Jung Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2013)
Chronic mild stress for modeling anhedonia
Ove Wiborg
CELL AND TISSUE RESEARCH (2013)
Ketamine and Peripheral Inflammation
Marc De Kock et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Treatment of Status Epilepticus with Ketamine, Are we There yet?
Frederic Dorandeu et al.
CNS NEUROSCIENCE & THERAPEUTICS (2013)
Talking to the Synapse: How Antidepressants Can Target Glial Cells to Reshape Brain Circuits
Barbara Benedetto et al.
CURRENT DRUG TARGETS (2013)
Nicotinic Receptors in Neurodegeneration
Inmaculada Posadas et al.
CURRENT NEUROPHARMACOLOGY (2013)
Resveratrol: New Avenues for a Natural Compound in Neuroprotection
Mercè Pallàs et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
INFLAMMATORY CYTOKINES IN DEPRESSION: NEUROBIOLOGICAL MECHANISMS AND THERAPEUTIC IMPLICATIONS
J. C. Felger et al.
NEUROSCIENCE (2013)
Neuroinflammation, Neurodegeneration, and Depression
Laura L. Hurley et al.
NEUROTOXICITY RESEARCH (2013)
Resveratrol Protects Cortical Neurons against Microglia-mediated Neuroinflammation
Feng Zhang et al.
PHYTOTHERAPY RESEARCH (2013)
Cholinergic receptors: functional role of nicotinic ACh receptors in brain circuits and disease
Jerrel L. Yakel
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2013)
Antidepressant effects of AMPA and ketamine combination: role of hippocampal BDNF, synapsin, and mTOR
Luli Akinfiresoye et al.
PSYCHOPHARMACOLOGY (2013)
Neuronal Network Plasticity and Recovery From Depression
Eero Castren
JAMA PSYCHIATRY (2013)
Neurobiology of Major Depressive Disorder
Rosa Villanueva
NEURAL PLASTICITY (2013)
Indistinguishable Synaptic Pharmacodynamics of the N-Methyl-D-Aspartate Receptor Channel Blockers Memantine and Ketamine
Christine M. Emnett et al.
MOLECULAR PHARMACOLOGY (2013)
Curcumin: A Potential Neuroprotective Agent in Parkinson's Disease
R. B. Mythri et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Curcumin and neurodegenerative diseases: a perspective
Altaf S. Darvesh et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Inhibition of Neuron-Specific CREB Dephosphorylation is Involved in Propofol and Ketamine-Induced Neuroprotection Against Cerebral Ischemic Injuries of Mice
Luowa Shu et al.
NEUROCHEMICAL RESEARCH (2012)
Signaling pathways underlying the rapid antidepressant actions of ketamine
Ronald S. Duman et al.
NEUROPHARMACOLOGY (2012)
Neurobiology of chronic mild stress: Parallels to major depression
Matthew N. Hill et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2012)
N-Methyl N-Nitrosourea Induced Functional and Structural Alterations in Mice Brain-Role of Curcumin
Neha Singla et al.
NEUROTOXICITY RESEARCH (2012)
Protective Effects of Nicotine Against Aminochrome-Induced Toxicity in Substantia Nigra Derived Cells: Implications for Parkinson's Disease
Patricia Munoz et al.
NEUROTOXICITY RESEARCH (2012)
Nicotinic Acetylcholine Receptor Agonists Attenuate Septic Acute Kidney Injury in Mice by Suppressing Inflammation and Proteasome Activity
Prodyot K. Chatterjee et al.
PLOS ONE (2012)
Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice
Franck Dhote et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression
Hiroyuki Koike et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Resveratrol improves cognitive function in mice by increasing production of insulin-like growth factor-I in the hippocampus
Naoaki Harada et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
Anti-inflammatory effects of nicotine in obesity and ulcerative colitis
Shaheen E. Lakhan et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Anita E. Autry et al.
NATURE (2011)
Toxic Effects of Low Alcohol and Nicotine Combinations in SH-SY5Y Cells are Apoptotically Mediated
Carlana Ramlochansingh et al.
NEUROTOXICITY RESEARCH (2011)
Nicotine Withdrawal-Induced Negative Affect Is a Function of Nicotine Dependence and Not Liability to Depression or Anxiety
Alexis C. Edwards et al.
NICOTINE & TOBACCO RESEARCH (2011)
Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF
Sheketha R. Hauser et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2011)
Cytokines mediated inflammation and decreased neurogenesis in animal models of depression
Cai Song et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Curcumin ameliorates reserpine-induced pain-depression dyad: Behavioural, biochemical, neurochemical and molecular evidences
V. Arora et al.
PSYCHONEUROENDOCRINOLOGY (2011)
Antidepressants: From MAOIs to SSRIs and more
VikramK Yeragani et al.
Indian Journal of Psychiatry (2011)
Curcumin and Alzheimer's Disease
Tsuyoshi Hamaguchi et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
Neuroprotection by Ketamine: A Review of the Experimental and Clinical Evidence
Judith A. Hudetz et al.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA (2010)
Nicotinic Modulation of Innate Immune Pathways Via α7 Nicotinic Acetylcholine Receptor
Wen-Yan Cui et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2010)
Effects of nicotine on depressive-like behavior and hippocampal volume of female WKY rats
Yousef Tizabi et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Nicotine and inflammatory neurological disorders
Wen-Hua Piao et al.
ACTA PHARMACOLOGICA SINICA (2009)
Multiple roles for nicotine in Parkinson's disease
Maryka Quik et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Depression and Immunity: Inflammation and Depressive Symptoms in Multiple Sclerosis
Stefan M. Gold et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2009)
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
Bharat B. Aggarwal et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration
Joan B. O'Sullivan et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2009)
Nicotinic Attenuation of Central Nervous System Inflammation and Autoimmunity
Fu-Dong Shi et al.
JOURNAL OF IMMUNOLOGY (2009)
Inhibitory Effects of Ketamine on Lipopolysaccharide-Induced Microglial Activation
Yi Chang et al.
MEDIATORS OF INFLAMMATION (2009)
The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression
Michael Maes et al.
METABOLIC BRAIN DISEASE (2009)
Additive Protective Effects of Donepezil and Nicotine Against Salsolinol-Induced Cytotoxicity in SH-SY5Y Cells
Jharna R. Das et al.
NEUROTOXICITY RESEARCH (2009)
Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes
Whit Kumar Bhutani et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Antidepressant-like effects of nicotine and reduced nicotinic receptor binding in the Fawn-Hooded rat, an animal model of co-morbid depression and alcoholism
Yousef Tizabi et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2009)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
Therapeutic potential of resveratrol in Alzheimer's disease
Valerie Vingtdeux et al.
BMC NEUROSCIENCE (2008)
Mechanisms and functional implications of adult neurogenesis
Chunmei Zhao et al.
CELL (2008)
Age-dependent effects of chronic stress on brain plasticity and depressive behavior
Erika Toth et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Antidepressant activity of curcumin: involvement of serotonin and dopamine system
Shrinivas K. Kulkarni et al.
PSYCHOPHARMACOLOGY (2008)
Nicotine effects on affective response in depression-prone smokers
Bonnie Spring et al.
PSYCHOPHARMACOLOGY (2008)
Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane)
Santosh K. Sandur et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Curcumin, demethtoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism
Santosh K. Sandur et al.
CARCINOGENESIS (2007)
What causes the hippocampal volume decrease in depression?
Boldizsar Czeh et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2007)
Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity
Robert L. Copeland et al.
NEUROTOXICITY RESEARCH (2007)
Influence of nicotine on positive affect in anhedonic smokers
Jessica Werth Cook et al.
PSYCHOPHARMACOLOGY (2007)
Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms
Song Li et al.
LIFE SCIENCES (2007)
Temporal relationship between cigarette smoking and risk of Parkinson disease
E. L. Thacker et al.
NEUROLOGY (2007)
Long-term changes in sleep and depressive symptoms of smokers in abstinence
Ana Moreno-Coutino et al.
NICOTINE & TOBACCO RESEARCH (2007)
Curry consumption and cognitive function in the elderly
Tze-Pin Ng et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Transdermal nicotine attenuates depression symptoms in nonsmokers: a double-blind, placebo-controlled trial
F. Joseph McClernon et al.
PSYCHOPHARMACOLOGY (2006)
Chronic oral nicotine treatment protects against striatal degeneration in MPTP-treated primates
Maryka Quik et al.
JOURNAL OF NEUROCHEMISTRY (2006)
A double-blind, placebo-controlled study of memantine in the treatment of major depression
CA Zarate et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
Neuroprotective effects of nicotine against salsolinol-induced cytotoxicity: Implications for Parkinson's disease
RL Copeland et al.
NEUROTOXICITY RESEARCH (2005)
Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats
Y Xu et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)
The effects of curcumin on depressive-like behaviors in mice
Y Xu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
The antiinflammatory effects of ketamine in endotoxemic rats during moderate and mild hypothermia
T Taniguchi et al.
ANESTHESIA AND ANALGESIA (2004)
Untreated depression and hippocampal volume loss
YI Sheline et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Effects of ketamine/xylazine on expression of tumor necrosis factor-α, inducible nitric oxide synthase, and cyclo-oxygenase-2 in rat gastric mucosa during endotoxemia
KS Helmer et al.
SHOCK (2003)
Ketamine/xylazine attenuates LPS-induced NOS expression in various rat tissues
KS Helmer et al.
JOURNAL OF SURGICAL RESEARCH (2003)
Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression
HK Manji et al.
BIOLOGICAL PSYCHIATRY (2003)
Dose-related effects of chronic antidepressants on neuroprotective proteins BDNF, bcl-2 and Cu/Zn-SOD in rat hippocampus
HY Xu et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats
K Sinha et al.
LIFE SCIENCES (2002)
Prevalence of dementia in an urban Indian population
CJ Vas et al.
INTERNATIONAL PSYCHOGERIATRICS (2001)
Ketamine inhibits endotoxin-induced shock in rats
T Taniguchi et al.
ANESTHESIOLOGY (2001)
Incidence of Alzheimer's disease in a rural community in India - The Indo-US Study
V Chandra et al.
NEUROLOGY (2001)
Smoking cessation and the course of major depression: a follow-up study
AH Glassman et al.
LANCET (2001)
Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease
GW Ross et al.
DRUGS & AGING (2001)
Central nicotinic receptors, neurotrophic factors and neuroprotection
N Belluardo et al.
BEHAVIOURAL BRAIN RESEARCH (2000)
Depressive characteristics of FSL rats: Involvement of central nicotinic receptors
Y Tizabi et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2000)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Development of major depression after treatment for smoking cessation
JY Tsoh et al.
AMERICAN JOURNAL OF PSYCHIATRY (2000)
分享论文
